Cholera Clinical Trials

Find Cholera Clinical Trials Near You

Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To evaluate the effectiveness of the CATI approach among household contacts in the reduction of cumulative incidence of cholera and explore the genome analysis and immune response of V. cholerae antigen from different hotspots in Dhaka city, cholera cases will be enrolled by rapid diagnostic test (RDT) from the diarrhoeal patients coming to icddr,b Dhaka hospital. Hotspots will be defined as the households (HHs) surrounding the RDT-positive cholera case (around 20-40m radius). The 'Case area targeted interventions' (CATI) will be given by administrating Oral Cholera Vaccine (OCV) with either one dose or two doses of OCV 1 month apart among household contacts (≥1-year age and non-pregnant women) and contacts of the contacts residing in the adjacent HHs. The passive surveillance for cholera will be followed using the icddr,b hospital, and other health facilities. Data on each individual's states of the clusters (e.g., susceptible, exposed, infectious, or recovered) will be tracked throughout the 3 years study follow-up.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: t
View:

• Some to severe dehydrated diarrheal patient

• Provide signed informed consent form

• Aged ≥1 year and non-pregnant

• Meeting the definition of IHC and NHC

• Provide signed informed consent form

Locations
Other Locations
Bangladesh
International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)
RECRUITING
Dhaka
Contact Information
Primary
Dr. Fahima Chowdhury, MBBS, MPH, PhD
fchowdhury@icddrb.org
+8801730016458
Time Frame
Start Date: 2024-09-05
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 68400
Treatments
Experimental: A) the intervention arm receiving a single dose
dose (\<5 years old children will receive two doses of OCV at 14 days interval according to the WHO guideline)
Experimental: B) the intervention arm receiving two doses at 1-month interval
No_intervention: C) no intervention or control arm
Related Therapeutic Areas
Sponsors
Leads: International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborators: Wellcome Sanger Institute

This content was sourced from clinicaltrials.gov